Coordinate regulation of metabolic enzymes and transporters by nuclear transcription factors in human liver disease

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 6, 2009, Pages 1038-1044

  Congiu, Mario ^a,b   Mashford, Maurice L ^a   Slavin, John L ^a   Desmond, Paul V ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Coordinate regulation; Liver disease; Metabolic enzymes; Nuclear receptors; Transporters

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; ENZYME; GLUCOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A6; GLUCURONOSYLTRANSFERASE 1A9; GLUCURONOSYLTRANSFERASE 2B4; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; PREGNANE X RECEPTOR; RETINOID X RECEPTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DRUG METABOLISM; ENZYME REGULATION; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; LIVER BIOPSY; LIVER DISEASE; LIVER FIBROSIS; MAJOR GENE; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS HEPATITIS;

ADULT; BIOPSY; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GLUCURONOSYLTRANSFERASE; HEPATITIS, VIRAL, HUMAN; HUMANS; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; STATISTICS, NONPARAMETRIC; TRANSCRIPTION FACTORS;

EID: 66549099938     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.05800.x     Document Type: Article

References (39)

1. Eloranta JJ, Meier PJ, Kullak-Ublick GA. Coordinate transcriptional regulation of transport and metabolism. Methods Enzymol. 2005 400 : 511 30.
2. Bock KW, Kohle C. Coordinate regulation of drug metabolism by xenobiotic nuclear receptors: UGTs acting together with CYPs and glucuronide transporters. Drug Metab. Rev. 2004 36 : 595 615. (Pubitemid 39453065)
3. Xu C, Li CY, Kong AN. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch. Pharm. Res. 2005 28 : 249 68.
4. Li N, Klaassen CD. Role of liver-enriched transcription factors in the down-regulation of organic anion transporting polypeptide 4 (oatp4; oatplb2; slc21a10) by lipopolysaccharide. Mol. Pharmacol. 2004 66 : 694 701. (Pubitemid 39329269)
5. Cheng X, Klaassen CD. Regulation of mRNA expression of xenobiotic transporters by the pregnane x receptor in mouse liver, kidney, and intestine. Drug Metab. Dispos. 2006 34 : 1863 7.
6. Jigorel E, Le Vee M, Boursier-Neyret C, Parmentier Y, Fardel O. Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes. Drug Metab. Dispos. 2006 34 : 1756 63.
7. Assenat E, Gerbal-Chaloin S, Larrey D et al. Interleukin 1beta inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance. Hepatology 2004 4 : 951 60.
8. Wang S, Hartley DP, Ciccotto SL, Vincent SH, Franklin RB, Kim MS. Induction of hepatic phase II drug-metabolizing enzymes by 1,7-phenanthroline in rats is accompanied by induction of MRP3. Drug Metab. Dispos. 2003 31 : 773 5.
9. Slitt AL, Cherrington NJ, Fisher CD, Negishi M, Klaassen CD. Induction of genes for metabolism and transport by trans-stilbene oxide in livers of Sprague-Dawley and Wistar-Kyoto rats. Drug Metab. Dispos. 2006 34 : 1190 7.
10. Wortham M, Czerwinski M, He L, Parkinson A, Wan YJ. Expression of constitutive androstane receptor, hepatic nuclear factor 4 alpha, and P450 oxidoreductase genes determines interindividual variability in basal expression and activity of a broad scope of xenobiotic metabolism genes in the human liver. Drug Metab. Dispos 2007 35 : 1700 10.
11. Hinoshita E, Taguchi K, Inokuchi A et al. Decreased expression of an ATP-binding cassette transporter, MRP2, in human livers with hepatitis C virus infection. J. Hepatol. 2001 35 : 765 73.
12. Yang LQ, Li SJ, Cao YF et al. Different alterations of cytochrome P450 3A4 isoform and its gene expression in livers of patients with chronic liver diseases. World J. Gastroenterol. 2003 9 : 359 63.
13. Congiu M, Mashford ML, Slavin JL, Desmond PV. UDP glucuronosyltransferase mRNA levels in human liver disease. Drug Metab. Dispos. 2002 30 : 129 34.
14. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996 24 : 289 93.
15. Maglich JM, Stoltz CM, Goodwin B, Hawkins-Brown D, Moore JT, Kliewer SA. Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol. Pharmacol. 2002 62 : 638 46.
16. Kuo CJ, Conley PB, Chen L, Sladek FM, Darnell JE Jr., Crabtree GR. A transcriptional hierarchy involved in mammalian cell-type specification. Nature 1992 355 : 457 61.
17. Gardner-Stephen DA, Mackenzie PI. Hepatocyte nuclear factor1 transcription factors are essential for the UDP-glucuronosyltransferase 1A9 promoter response to hepatocyte nuclear factor 4alpha. Pharmacogenet. Genomics 2007 17 : 25 36. (Pubitemid 46195060)
18. Knight JA. Liver function tests: their role in the diagnosis of hepatobiliary diseases. J. Infus. Nurs. 2005 28 : 108 17.
19. Reedy DW, Loo AT, Levine RA. AST/ALT ratio > or = 1 is not diagnostic of cirrhosis in patients with chronic hepatitis C. Dig. Dis. Sci. 1998 43 : 2156 9.
20. Sanai FM, Benmousa A, Al-Hussaini H et al. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection? Liver Int. 2008 28 : 1011 18.
21. George J, Liddle C, Murray M, Byth K, Farrell GC. Pre-translational regulation of cytochrome P450 genes is responsible for disease-specific changes of individual P450 enzymes among patients with cirrhosis. Biochem. Pharmacol. 1995 49 : 873 81.
22. Fang C, Yoon S, Tindberg N, Jarvelainen HA, Lindros KO, Ingelman-Sundberg M. Hepatic expression of multiple acute phase proteins and down-regulation of nuclear receptors after acute endotoxin exposure. Biochem. Pharmacol. 2004 67 : 1389 97.
23. Debinski HS, Lee CS, Danks JA, Mackenzie PI, Desmond PV. Localization of uridine 5′-diposphate-glucuronosyltransferase in human liver injury. Gastroenterology 1995 108 : 1464 9.
24. Debinski HS, Mackenzie PI, Lee CS et al. UDP glucuronosyltransferase in the cirrhotic rat liver. J. Gastroenterol. Hepatol. 1996 11 : 373 9.
25. Yang LQ, Li SJ, Cao YF et al. Different alterations of cytochrome P450 3A4 isoform and its gene expression in livers of patients with chronic liver diseases. World J. Gastroenterol. 2003 9 : 359 63.
26. Ros JE, Libbrecht L, Geuken M, Jansen PL, Roskams TA. High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver disease. J. Pathol. 2003 200 : 553 60.
27. Yu SL, Chen HW, Yang PC et al. Differential gene expression in gram-negative and gram-positive sepsis. Am. J. Respir. Crit. Care Med. 2004 169 : 1135 43.
28. Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW. Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression. Am. J. Pathol. 2002 160 : 641 54.
29. Zhou C, Tabb MM, Nelson EL et al. Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation. Clin. Invest. 2006 116 : 2280 9.
30. Renton KW. Cytochrome P450 regulation and drug biotransformation during inflammation and infection. Curr. Drug Metab. 2004 5 : 235 43.
31. Aitken AE, Richardson TA, Morgan ET. Regulation of drug-metabolizing enzymes and transporters in inflammation. Annu. Rev. Pharmacol. Toxicol. 2006 46 : 123 49.
32. Morgan ET. Regulation of cytochrome p450 by inflammatory mediators: why and how? Drug Metab. Dispos. 2001 29 : 207 12.
33. Tsutsumi T, Suzuki T, Shimoike T et al. Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity. Hepatology 2002 35 : 937 46.
34. Shedlofsky SI, Israel BC, McClain CJ, Hill DB, Blouin RA. Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism. J. Clin. Invest. 1994 94 : 2209 14.
35. Siewert E, Bort R, Kluge R, Heinrich PC, Castell J, Jover R. Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent. Hepatology 2000 32 : 49 55. (Pubitemid 30432365)
36. Crawford JH, Yang S, Zhou M, Simms HH, Wang P. Down-regulation of hepatic CYP1A2 plays an important role in inflammatory responses in sepsis. Crit. Care Med. 2004 32 : 502 8.
37. Carcillo JA, Korzekwa KR, Jones GS et al. The cytochrome P450 suicide inhibitor, 1-aminobenzotriazole, sensitizes rats to zymosan-induced toxicity. Res. Commun. Mol. Pathol. Pharmacol. 1998 102 : 57 68. (Pubitemid 29058452)
38. Bertrand-Thiébault C, Berrahmoune H, Thompson A et al. Genetic Polymorphism of CYP2C19 gene in the Stanislas cohort. A link with inflammation. Ann. Hum. Genet. 2008 72 : 178 83.
39. Stoilov I, Krueger W, Mankowski D et al. The cytochromes P450 (CYP) response to allergic inflammation of the lung. Arch. Biochem. Biophys. 2006 456 : 30 8.